Sandy Draper
Stock Analyst at Guggenheim
(2.91)
# 1,486
Out of 5,115 analysts
113
Total ratings
59.14%
Success rate
20.63%
Average return
Main Sectors:
Stocks Rated by Sandy Draper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Maintains: Buy | $464 → $432 | $582.48 | -25.83% | 12 | Jul 24, 2024 | |
| EVH Evolent Health | Maintains: Hold | $34 → $28 | $3.21 | +772.27% | 10 | May 14, 2024 | |
| IQV IQVIA Holdings | Downgrades: Neutral | n/a | $230.15 | - | 8 | Feb 15, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Neutral | n/a | $210.48 | - | 15 | Feb 15, 2024 | |
| GDRX GoodRx Holdings | Maintains: Buy | $8 → $10 | $2.27 | +340.53% | 4 | Aug 10, 2023 | |
| DOCS Doximity | Downgrades: Neutral | n/a | $37.47 | - | 3 | Aug 9, 2023 | |
| TOI The Oncology Institute | Maintains: Buy | $3 → $2 | $2.71 | -26.20% | 3 | Jun 16, 2023 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $271 → $263 | $180.25 | +45.91% | 13 | Apr 28, 2023 | |
| AGL agilon health | Maintains: Buy | $21 → $30 | $0.83 | +3,504.90% | 3 | Mar 6, 2023 | |
| HQY HealthEquity | Maintains: Buy | $89 → $94 | $85.59 | +9.83% | 11 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $5.45 | - | 10 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $51 | $23.22 | +119.64% | 2 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $143 → $129 | $231.14 | -44.19% | 2 | May 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $55 | $38.08 | +44.43% | 2 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $226 → $168 | $102.34 | +64.16% | 2 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $12 | $27.09 | -55.70% | 1 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $9.37 | +433.62% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $65 | $12.06 | +438.97% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $2.15 | +1,574.42% | 4 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $167 | $203.92 | -18.11% | 3 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $0.92 | - | 2 | May 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $63 | $8.98 | +601.56% | 1 | Sep 20, 2016 |
Medpace Holdings
Jul 24, 2024
Maintains: Buy
Price Target: $464 → $432
Current: $582.48
Upside: -25.83%
Evolent Health
May 14, 2024
Maintains: Hold
Price Target: $34 → $28
Current: $3.21
Upside: +772.27%
IQVIA Holdings
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $230.15
Upside: -
Charles River Laboratories International
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $210.48
Upside: -
GoodRx Holdings
Aug 10, 2023
Maintains: Buy
Price Target: $8 → $10
Current: $2.27
Upside: +340.53%
Doximity
Aug 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $37.47
Upside: -
The Oncology Institute
Jun 16, 2023
Maintains: Buy
Price Target: $3 → $2
Current: $2.71
Upside: -26.20%
ICON Public Limited Company
Apr 28, 2023
Maintains: Buy
Price Target: $271 → $263
Current: $180.25
Upside: +45.91%
agilon health
Mar 6, 2023
Maintains: Buy
Price Target: $21 → $30
Current: $0.83
Upside: +3,504.90%
HealthEquity
Dec 7, 2022
Maintains: Buy
Price Target: $89 → $94
Current: $85.59
Upside: +9.83%
Oct 24, 2022
Upgrades: Neutral
Price Target: n/a
Current: $5.45
Upside: -
Aug 12, 2022
Maintains: Buy
Price Target: $36 → $51
Current: $23.22
Upside: +119.64%
May 25, 2021
Maintains: Buy
Price Target: $143 → $129
Current: $231.14
Upside: -44.19%
May 18, 2021
Maintains: Buy
Price Target: $84 → $55
Current: $38.08
Upside: +44.43%
May 12, 2021
Maintains: Buy
Price Target: $226 → $168
Current: $102.34
Upside: +64.16%
Apr 21, 2021
Initiates: Hold
Price Target: $12
Current: $27.09
Upside: -55.70%
Jan 28, 2021
Initiates: Buy
Price Target: $50
Current: $9.37
Upside: +433.62%
Jan 28, 2021
Initiates: Buy
Price Target: $65
Current: $12.06
Upside: +438.97%
May 13, 2020
Maintains: Buy
Price Target: $30 → $36
Current: $2.15
Upside: +1,574.42%
Mar 26, 2020
Maintains: Buy
Price Target: $175 → $167
Current: $203.92
Upside: -18.11%
May 31, 2017
Upgrades: Buy
Price Target: n/a
Current: $0.92
Upside: -
Sep 20, 2016
Initiates: Buy
Price Target: $63
Current: $8.98
Upside: +601.56%